Equate Bismuth Stomach Relief Chew

Manufacturer
Walmart | Bestco
Effective date
2025-12-23
Label type
HUMAN OTC DRUG LABEL
Version
3
Source
full-release
Hydrated at
2026-06-01 01:28:13

Label at a glance#

ProductEquate Bismuth Stomach Relief Chew
Active ingredientBISMUTH SUBSALICYLATE
Label structure17 sections

Label contents#

Full prescribing information#

OTC - ACTIVE INGREDIENT SECTION

Active ingredient (in each chewable tablet)

Bismuth subsalicylate 262 mg

OTC - PURPOSE SECTION

Purpose

Upset stomach reliever and antidiarrheal

INDICATIONS & USAGE SECTION

Uses relieves

  • Traveler's diarrhea
  • Diarrhea
  • Upset stomach due to overindulgence in food and drink, including:
  • Heartburn
  • Indigestion
  • Nausea
  • Gas
  • Belching
  • Fullness

WARNINGS SECTION

Warnings

Reye's syndrome: Children and teenagers who have or are recovering from chicken pox or flu-like symptoms should not use this product. When using this product, if changes in behavior with nausea and vomiting occur, consult a doctor because these symptoms could be an early sign of Reye's syndrome, a rare but serious illness.

OTC - DO NOT USE SECTION

Allergy alert: Contains salicylate. Do not take if you are

  • Allergic to salicylates (including aspirin)
  • taking other salicylate products

Do not use if you have

  • An ulcer
  • A bleeding problem
  • Bloody or black stool

OTC - ASK DOCTOR SECTION

Ask a doctor before use if you have

  • Fever
  • Mucus in the stool

OTC - ASK DOCTOR/PHARMACIST SECTION

Ask a doctor or pharmacist before use if you are taking any drug for

  • Anticoagulation (thinning the blood)
  • Diabetes
  • Gout
  • Arthritis

OTC - WHEN USING SECTION

When using this product a temporary, but harmless, darkening of the stool and/or tongue may occur

OTC - STOP USE SECTION

Stop use and ask a doctor if

  • Symptoms get worse or last more than 2 days
  • Ringing in the ears or loss of hearing occurs
  • Diarrhea lasts more than 2 days

OTC - PREGNANCY OR BREAST FEEDING SECTION

If pregnant or breast-feeding, ask a health professional before use.

OTC - KEEP OUT OF REACH OF CHILDREN SECTION

Keep out of reach of children.

OVERDOSAGE SECTION

In case of overdose, get medical help or contact a Poison Control Center right away.

DOSAGE & ADMINISTRATION SECTION

Directions

  • Fully chew before swallowing
  • Adults and children 12 years and over:
  • 2 chewable tablets every 1/2 hour or 4 chewable tablets every hour as needed for diarrhea.
  • 2 chewable tablets every 1/2 hour to 1 hour as needed for overindulgence (upset stomach, heartburn, indigestion, nausea).
  • Do not exceed 8 doses (16 chewable tablets) in 24 hours
  • Use until diarrhea stops but not more than 2 days
  • Children under 12 years: ask a doctor
  • Drink plenty of clear fluids to help prevent dehydration caused by diarrhea.

INACTIVE INGREDIENT SECTION

Inactive ingredients: Beeswax, calcium carbonate, carmine, carnauba wax, citric acid, corn starch, corn syrup, dextrin, ethyl acetate, glycerin, FD&C red no. 40 aluminum lake, FD&C yellow no. 6 aluminum lake, gum arabic, hydrogenated coconut oil, maltodextrin, natural and artificial flavors, phosphoric acid, propylene glycol, shellac, sodium benzoate, sorbic acid, sorbitol, soy lecithin, sucrose, titanium dioxide, vegetable oil (coconut and/or canola oil), water.

OTHER SAFETY INFORMATION

Other information

  • Each chewable tablet contains: Calcium 50mg
  • Salicylate 123mg
  • Low sodium
  • Store at no greater than 25°C (77°F). Avoid excessive heat (over 40°C).

OTC - QUESTIONS SECTION

Questions? Call 1-888-287-1915 Monday - Friday, 9AM to 4PM EST

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

Equate Bismuth Stomach Relief Chews 24ctEquate Bismuth Stomach Relief Chews 24ct

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUIRxNorm stringTTYSPL version
308761bismuth subsalicylate 262 MG Chewable TabletPSN3
308761bismuth subsalicylate 262 MG Chewable TabletSCD3

DailyMed Pharmacologic Classes#

Class, Version, Type table
ClassVersionTypeEffective
BISMUTH CATION Pharmacologic Class Indexing2Indexing - Pharmacologic Class20180813

Product Linked Resources#

Resource, Code type, Value table
ResourceCode typeValueEquivalent identifiersSource image
BarcodeEAN-130194346112241GTIN-13: 0194346112241
EAN-13: 0194346112241
GTIN-12: 194346112241
UPC-A: 194346112241
GTIN storage (14 digits): 00194346112241
Equate Bismuth Stomach Relief Chew 24ct.jpg

DailyMed Product Concepts#

Product concept, Relation, Version table
Product conceptRelationVersionEffective
0be8e4ae-4d57-49f3-b3a9-e4728b4e8d15Product name120240313
dea2eded-d1e7-46bb-9a3d-f8dc20de6277Product name120190408

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
79903-219-24Equate Bismuth Stomach Relief Chew24 in 1 BOTTLETABLET, CHEWABLE243

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 4 matching rows.

NDC Codes#

Product NDC, Package NDC table
Product NDCPackage NDC
79903-21979903-219-24

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 2 matching rows.

Name, UNII, Kind table
NameUNIIKind
WATER059QF0KO0RIACT
BISMUTH SUBSALICYLATE62TEY51RR1ACTIB

Source Document#

Source XML

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
Equate Bismuth Stomach Relief ChewBISMUTH SUBSALICYLATEWalmart09967ac3-0013-c6ea-e063-6294a90a38d42025-12-23WarningsExact identifier
ndc (package): 79903-219-24
ndc (product): 79903-219
ndc11 (package): 79903021924
spl id: 46a30344-5b0b-72b9-e063-6394a90a01b5
spl set id: 09967ac3-0013-c6ea-e063-6294a90a38d4

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.